Literature DB >> 27072804

Engineering microbial hosts for production of bacterial natural products.

Mingzi M Zhang1, Yajie Wang, Ee Lui Ang, Huimin Zhao.   

Abstract

Covering up to end 2015Microbial fermentation provides an attractive alternative to chemical synthesis for the production of structurally complex natural products. In most cases, however, production titers are low and need to be improved for compound characterization and/or commercial production. Owing to advances in functional genomics and genetic engineering technologies, microbial hosts can be engineered to overproduce a desired natural product, greatly accelerating the traditionally time-consuming strain improvement process. This review covers recent developments and challenges in the engineering of native and heterologous microbial hosts for the production of bacterial natural products, focusing on the genetic tools and strategies for strain improvement. Special emphasis is placed on bioactive secondary metabolites from actinomycetes. The considerations for the choice of host systems will also be discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27072804      PMCID: PMC4963277          DOI: 10.1039/c6np00017g

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN: 0265-0568            Impact factor:   13.423


  289 in total

1.  Novel approach for improving the productivity of antibiotic-producing strains by inducing combined resistant mutations.

Authors:  H Hu; K Ochi
Journal:  Appl Environ Microbiol       Date:  2001-04       Impact factor: 4.792

2.  Controlling the metabolic flux through the carotenoid pathway using directed mRNA processing and stabilization.

Authors:  C D Smolke; V J Martin; J D Keasling
Journal:  Metab Eng       Date:  2001-10       Impact factor: 9.783

3.  Genome shuffling leads to rapid phenotypic improvement in bacteria.

Authors:  Ying-Xin Zhang; Kim Perry; Victor A Vinci; Keith Powell; Willem P C Stemmer; Stephen B del Cardayré
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

4.  Metabolic engineering by genome shuffling.

Authors:  Gregory Stephanopoulos
Journal:  Nat Biotechnol       Date:  2002-07       Impact factor: 54.908

5.  Engineering of primary carbon metabolism for improved antibiotic production in Streptomyces lividans.

Authors:  Michael J Butler; Per Bruheim; Srdjan Jovetic; Flavia Marinelli; Pieter W Postma; Mervyn J Bibb
Journal:  Appl Environ Microbiol       Date:  2002-10       Impact factor: 4.792

6.  Cloning and characterization of a phosphopantetheinyl transferase from Streptomyces verticillus ATCC15003, the producer of the hybrid peptide-polyketide antitumor drug bleomycin.

Authors:  C Sánchez; L Du; D J Edwards; M D Toney; B Shen
Journal:  Chem Biol       Date:  2001-07

7.  Phage R4 integrase mediates site-specific integration in human cells.

Authors:  E C Olivares; R P Hollis; M P Calos
Journal:  Gene       Date:  2001-10-31       Impact factor: 3.688

8.  Mapping the DNA-binding domain and target sequences of the Streptomyces peucetius daunorubicin biosynthesis regulatory protein, DnrI.

Authors:  Paul J Sheldon; Sara B Busarow; C Richard Hutchinson
Journal:  Mol Microbiol       Date:  2002-04       Impact factor: 3.501

9.  Activation of antibiotic biosynthesis by specified mutations in the rpoB gene (encoding the RNA polymerase beta subunit) of Streptomyces lividans.

Authors:  Haifeng Hu; Qin Zhang; Kozo Ochi
Journal:  J Bacteriol       Date:  2002-07       Impact factor: 3.490

10.  A rifampicin resistance mutation in the rpoB gene confers ppGpp-independent antibiotic production in Streptomyces coelicolor A3(2).

Authors:  J Xu; Y Tozawa; C Lai; H Hayashi; K Ochi
Journal:  Mol Genet Genomics       Date:  2002-08-15       Impact factor: 3.291

View more
  35 in total

Review 1.  Streptomycetes: Surrogate hosts for the genetic manipulation of biosynthetic gene clusters and production of natural products.

Authors:  Keshav K Nepal; Guojun Wang
Journal:  Biotechnol Adv       Date:  2018-10-09       Impact factor: 14.227

Review 2.  Heterologous expression-facilitated natural products' discovery in actinomycetes.

Authors:  Min Xu; Gerard D Wright
Journal:  J Ind Microbiol Biotechnol       Date:  2018-11-16       Impact factor: 3.346

Review 3.  Using natural products for drug discovery: the impact of the genomics era.

Authors:  Mingzi M Zhang; Yuan Qiao; Ee Lui Ang; Huimin Zhao
Journal:  Expert Opin Drug Discov       Date:  2017-03-14       Impact factor: 6.098

Review 4.  Recent metabolomics and gene editing approaches for synthesis of microbial secondary metabolites for drug discovery and development.

Authors:  Rajeshwari Sinha; Babita Sharma; Arun Kumar Dangi; Pratyoosh Shukla
Journal:  World J Microbiol Biotechnol       Date:  2019-10-22       Impact factor: 3.312

Review 5.  Breaking the silence: new strategies for discovering novel natural products.

Authors:  Hengqian Ren; Bin Wang; Huimin Zhao
Journal:  Curr Opin Biotechnol       Date:  2017-03-11       Impact factor: 9.740

6.  Heterologous Production of Lasso Peptide Capistruin in a Burkholderia Host.

Authors:  Sylvia Kunakom; Alessandra S Eustáquio
Journal:  ACS Synth Biol       Date:  2020-01-13       Impact factor: 5.110

Review 7.  Targeted Large-Scale Genome Mining and Candidate Prioritization for Natural Product Discovery.

Authors:  Jessie James Limlingan Malit; Hiu Yu Cherie Leung; Pei-Yuan Qian
Journal:  Mar Drugs       Date:  2022-06-16       Impact factor: 6.085

8.  An isotopic labeling approach linking natural products with biosynthetic gene clusters.

Authors:  Catherine S McCaughey; Jeffrey A van Santen; Justin J J van der Hooft; Marnix H Medema; Roger G Linington
Journal:  Nat Chem Biol       Date:  2021-12-30       Impact factor: 16.174

Review 9.  Targeting Bacterial Genomes for Natural Product Discovery.

Authors:  Edward Kalkreuter; Guohui Pan; Alexis J Cepeda; Ben Shen
Journal:  Trends Pharmacol Sci       Date:  2019-12-07       Impact factor: 14.819

Review 10.  Streptomyces: host for refactoring of diverse bioactive secondary metabolites.

Authors:  Vivek Sharma; Randhir Kaur; Richa Salwan
Journal:  3 Biotech       Date:  2021-06-16       Impact factor: 2.893

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.